Key result
Ouabain augments myocardial contractility, increasing shortening velocity by ~77% without increasing cardiac output.
Why the study?
Does ouabain (0.01 mg/kg) augment myocardial contractility in patients who have undergone corrective cardiac operations?
Does ouabain (0.01 mg/kg) augment myocardial contractility in patients who have undergone corrective cardiac operations?
Digitalis glycosides fundamentally augment the contractile state of the heart, but this does not translate to increased cardiac output in the absence of heart failure.
Answers are grounded in this paper and cite their sources.
Caution against expecting output gains from ouabain in stable post-surgical patients; leaves open its role in euvolemic states.
The effects of ouabain (0.01 mg/kg) on ventricular force-velocity relations were studied in six patients who had previously undergone corrective cardiac operations. The technique employed consisted of exposing cineradiograms at 30 frames per second and measuring the velocity of movement of roentgen-opaque markers that had been sutured to the external surfaces of the ventricles while simultaneously recording intraventricular pressures. A beat-to-beat analysis of the ventricular force-velocity relation was then accomplished by relating the velocity of marker movement and intraventricular pressure at constant ventricular dimensions. It was observed that ouabain always augmented myocardial contractility as reflected in the force-velocity relation. Velocity of shortening increased an average of 77±5 ( sem )% while intraventricular pressure rose by an average of 23±6%. Despite this improvement in contractility, no consistent changes in cardiac output were observed. Analogous changes in force-velocity curves were obtained when a cardiac glycoside was added to isolated papillary muscles removed from normal cats. It is concluded that the fundamental action of digitalis glycosides is to augment the contractile state of the heart, whether normal or failing, but that in the absence of heart failure this improvement is not translated into an increase in cardiac output.
No takes yet. Share an insight, caveat, or question.
Sonnenblick et al. (1966) studied Prior corrective cardiac operations (n=6). Ouabain was evaluated on Ventricular force-velocity relations (velocity of shortening and intraventricular pressure). Ouabain administration augmented myocardial contractility, increasing velocity of shortening by an average of 77±5% and intraventricular pressure by 23±6%, without increasing cardiac output.
Synapse has enriched 10 related papers. Consider them for comparative context: